Faïza Omar
Biographic Data
| ID | 7750282 |
|---|---|
| NAME | Faïza Omar |
| GIVEN NAMES | Faïza |
| FAMILY NAME | Omar |
| SIGNATURE | OMAR F |
| AFFILIATIONS | Institute of Public Affairs |
| VERIFIED | No |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 3 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2023 |
| LATEST PUBLICATION YEAR | 2024 |
| H-INDEX | 0 |
Risk of Sars-CoV-2 infection in professional settings, shops, shared transport, and leisure activities in France, 2020–2022
GOV (03/09/2022): NCT04607941
Source of Sars-CoV-2 infection: Results from a series of 584,846 cases in France from October 2020 to August 2022
ClinicalTrials.gov registration number: NCT04607941
Reduction of Sars-CoV-2 intra-household child-to-parent transmission associated with ventilation: Results from a case–control study
ClinicalTrials.gov registration number: NCT04607941
No prominent works on this page.
Reduction of Sars-CoV-2 intra-household child-to-parent transmission associated with ventilation: Results from a case–control study
ClinicalTrials.gov registration number: NCT04607941
Risk of Sars-CoV-2 infection in professional settings, shops, shared transport, and leisure activities in France, 2020–2022
GOV (03/09/2022): NCT04607941
Source of Sars-CoV-2 infection: Results from a series of 584,846 cases in France from October 2020 to August 2022
ClinicalTrials.gov registration number: NCT04607941
Biostatistics (3 works) · Coronavirus disease 2019 (COVID-19 (3 works) · COVID-19 epidemiological studies (3 works) · Demography (3 works) · Demography (3 works) · Disease (3 works) · Environmental health (3 works) · Epidemiology (3 works) · Infectious disease (medical specialty (3 works) · Internal Medicine (3 works)